119 related articles for article (PubMed ID: 25249029)
1. Scientific, economic, regulatory, and ethical challenges of bringing science-based pediatric nutrition products to the U.S. market and ensuring their availability for patients.
Merritt RJ; Goldsmith AH
JPEN J Parenter Enteral Nutr; 2014 Nov; 38(2 Suppl):17S-34S. PubMed ID: 25249029
[TBL] [Abstract][Full Text] [Related]
2. Nutritional supplements and tube feeds: what is available?
White G
Br J Nurs; 1998 Mar 12-25; 7(5):246-50, 252, 254-5. PubMed ID: 9616544
[TBL] [Abstract][Full Text] [Related]
3. The economics of pediatric formulation development for off-patent drugs.
Milne CP; Bruss JB
Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
[TBL] [Abstract][Full Text] [Related]
4. Drug shortages: a complex health care crisis.
Fox ER; Sweet BV; Jensen V
Mayo Clin Proc; 2014 Mar; 89(3):361-73. PubMed ID: 24582195
[TBL] [Abstract][Full Text] [Related]
5. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
Giacoia GP; Taylor-Zapata P; Zajicek A
Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
[TBL] [Abstract][Full Text] [Related]
6. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.
International Liaison Committee on Resuscitation
Pediatrics; 2006 May; 117(5):e955-77. PubMed ID: 16618790
[TBL] [Abstract][Full Text] [Related]
7. Launching a new food product or dietary supplement in the United States: industrial, regulatory, and nutritional considerations.
Finley JW; Finley JW; Ellwood K; Hoadley J
Annu Rev Nutr; 2014; 34():421-47. PubMed ID: 24850389
[TBL] [Abstract][Full Text] [Related]
8. Nutraceuticals and botanicals: overview and perspectives.
Nicoletti M
Int J Food Sci Nutr; 2012 Mar; 63 Suppl 1():2-6. PubMed ID: 22360273
[TBL] [Abstract][Full Text] [Related]
9. Probiotics--the friendly bacteria with market potential in global market.
Khan SH; Ansari FA
Pak J Pharm Sci; 2007 Jan; 20(1):76-82. PubMed ID: 17337434
[TBL] [Abstract][Full Text] [Related]
10. Pediatric drug shortages: a deplorable fact and a political problem.
Shader RI
Clin Ther; 2014 Feb; 36(2):151-2. PubMed ID: 24529285
[No Abstract] [Full Text] [Related]
11. [Why do good drugs disappear?].
Brezis M; Tomer R; Klang S; Hammerman A
Harefuah; 2010 Oct; 149(10):652-5, 683. PubMed ID: 21568061
[TBL] [Abstract][Full Text] [Related]
12. Advancing pharmaceutical quality: An overview of science and research in the U.S. FDA's Office of Pharmaceutical Quality.
Fisher AC; Lee SL; Harris DP; Buhse L; Kozlowski S; Yu L; Kopcha M; Woodcock J
Int J Pharm; 2016 Dec; 515(1-2):390-402. PubMed ID: 27773853
[TBL] [Abstract][Full Text] [Related]
13. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs.
Noah L
S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891
[TBL] [Abstract][Full Text] [Related]
14. The drugs stop here: a public health framework to address the drug shortage crisis.
Hoffman S
Food Drug Law J; 2012; 67(1):1-21, i. PubMed ID: 24624646
[TBL] [Abstract][Full Text] [Related]
15. Family pediatrics: report of the Task Force on the Family.
Schor EL;
Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
[TBL] [Abstract][Full Text] [Related]
16. The changing environment for technological innovation in health care.
Goodman CS; Gelijns AC
Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
[TBL] [Abstract][Full Text] [Related]
17. Protect pharmaceutical innovation.
Musselwhite LW; Andrews J
Science; 2010 Jun; 328(5984):1354; author reply 1354-5. PubMed ID: 20538934
[No Abstract] [Full Text] [Related]
18. [Haute Autorite de sante opinion on cost-effectiveness of health products : results and perspectives].
Midy F; Raimond V; Thébaut C; Sambuc C; Rumeau-Pichon C
Sante Publique; 2015; 27(5):691-700. PubMed ID: 26752035
[TBL] [Abstract][Full Text] [Related]
19. Food-pharma convergence in medical nutrition- best of both worlds?
Weenen TC; Ramezanpour B; Pronker ES; Commandeur H; Claassen E
PLoS One; 2013; 8(12):e82609. PubMed ID: 24358214
[TBL] [Abstract][Full Text] [Related]
20. Parenteral nutrition product shortages: the A.S.P.E.N. strategy.
Mirtallo JM; Holcombe B; Kochevar M; Guenter P
Nutr Clin Pract; 2012 Jun; 27(3):385-91. PubMed ID: 22513703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
